Clinical characteristics and survival outcomes of TFE3-rearranged renal cell carcinoma: a retrospective study compared with clear cell renal cell carcinoma using propensity score matching - Top-Institutions - MDSpire

Clinical characteristics and survival outcomes of TFE3-rearranged renal cell carcinoma: a retrospective study compared with clear cell renal cell carcinoma using propensity score matching

  • By

  • Wencong Han

  • Kun Peng

  • Qi Shen

  • Shiwei Chen

  • Zejin Ou

  • Tai Kang

  • Xiaojun Yu

  • Jianbin Zhang

  • Zheng Zhang

  • October 31, 2025

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Molecular Pathology
    • Genomic Medicine

  • #2

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Urologic Oncology
    • Cancer Genomics
    • Pathology

  • #3

    Dana-Farber/Brigham and Women’s Cancer Center
    Dana-Farber/Brigham and Women’s Cancer Center

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Urologic Oncology
    • Molecular Diagnostics

  • #4

    Peking University First Hospital
    Peking University First Hospital

    Beijing, Beijing

    Key Differentiators

    • Urology
    • Genitourinary Pathology
    • Molecular Oncology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Molecular Pathology
    • Genomic Medicine

Original Source(s)

Clinical characteristics and survival outcomes of TFE3-rearranged renal cell carcinoma: a retrospective study compared with clear cell renal cell carcinoma using propensity score matching

  • by Wencong Han, Kun Peng, Qi Shen, Shiwei Chen, Zejin Ou, Tai Kang, Xiaojun Yu, Jianbin Zhang, Zheng Zhang

  • October 31, 2025

Related Content

Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update

Adjuvant Treatment Approaches for Renal Cell Carcinoma: Insights from Historical Challenges and Emerging Possibilities with Immune Checkpoint Inhibitors

Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1)

Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): Post-hoc analysis of CheckMate 214.

  • February 26, 2025

  • 1 min